Relay Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$15.88

+0.32 (+2.06%)

As of Jun 21, 10:07 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +310.8% upside

Low Target $47.67

Average Target $65.23

High Target $99.61

Current Price $15.88

Current
$15.88

Target
$65.23

$47.67 $65.23 avg $99.61

Scenario Analysis

Bear Case

$47.67

200.2%

Low target

Base Case

$65.23

+310.8%

Avg target

Bull Case

$99.61

+527.3%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$17.47

-9.1% from high

52-Week Low

$2.98

+432.9% from low

Target vs 52W High

$65.23

+273.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.6%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+188.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.9%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.4%